An Evaluation of the Effect of Vitamin D Supplementation on Depressive Symptoms Among Chinese Early Adolescents

Last updated: June 28, 2025
Sponsor: Anhui Medical University
Overall Status: Completed

Phase

N/A

Condition

Depression

Treatment

Vitamin D3

Mental health education

Vitamin D3 placebo

Clinical Study ID

NCT06247930
84230079
  • Ages 10-15
  • All Genders

Study Summary

The goal of this randomized controlled clinical trial is to investigate the effects of vitamin D3 supplementation on depression in Chinese early adolescents with elevated depressive symptoms and vitamin D deficiency. The main question it aims to answer whether vitamin D3 supplementation can reduce depressive symptoms.

Participants in the intervention group will receive vitamin D3 capsules and mental health education. The control group will receive vitamin D3 placebo and mental health education.

Researchers will compare the change in depressive symptoms from baseline to post-intervention at 12 weeks between the intervention and control groups.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. 7th-9th students whose caregivers signed informed consents;

  2. students with serum 25(OH)D concentrations below 20 ng/mL;

  3. students with self-reported depressive symptoms (BDI-II score of 14 or higher)

Exclusion

Exclusion Criteria:

  1. students who are currently receiving or have used anti-psychotic treatments orinterventions (including drugs and non-drugs) in the past 3 months;

  2. students who have serious health conditions (e.g., organic or functional braindiseases, major psychiatric disorders, cardiovascular diseases, serious infectiousdiseases, chronic gastrointestinal diseases, and hepatic or renal diseases);

  3. students who are currently taking or have taken vitamin D supplements in the past 3months;

  4. students with self-reported serious suicidal ideation, suicidal plans and attemptsin the past 3 months;

  5. students with intellectual disability;

  6. students who are allergic to vitamin D or soybean oil components.

Study Design

Total Participants: 406
Treatment Group(s): 3
Primary Treatment: Vitamin D3
Phase:
Study Start date:
March 19, 2024
Estimated Completion Date:
June 24, 2025

Study Description

Investigators will conduct a randomized controlled trial to examine whether vitamin D3 supplementation can improve depressive symptoms. Participants will be recruited from two middle schools. Participants will be randomly assigned into a supplementation or placebo group. Supplementation arm will receive oral dose 2000 IU vitamin D3 per day for 6 weeks and followed by 800 IU per day for 6 weeks; placebo arm will receive placebo every day for 12 weeks. Both of these two groups will receive additional mental health education. For the first 6 weeks, vitamin D or placebo will be administrated every two weeks. For the next 6 weeks, vitamin D or placebo will be administrated every three weeks. The primary outcome of this study is to compare the change of depressive symptoms between supplementation or placebo group from pre- to post-intervention at 12 weeks.

Connect with a study center

  • Susong County Guangfu Middle School

    Anqing, Anhui 246500
    China

    Site Not Available

  • Susong County Zhenxing School

    Anqing, Anhui 246500
    China

    Site Not Available

  • Suzon County Guangfu Middle School

    Anqing, Anhui 246500
    China

    Active - Recruiting

  • Feidong County No. 4 Middle School

    Hefei, Anhui 231600
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.